Identification of genetic polymorphisms of human OAT1 and OAT2 genes and their relationship to hOAT2 expression in human liver

Clinica Chimica Acta

Volumn 411, Issue 1-2, 2010, Pages 99-105

  Shin, Ho Jung ^a   Lee, Choong Hee ^a   Lee, Sang Seop ^a   Song, Im Sook ^a   Shin, Jae Gook ^a  

^a Inje University College of Medicine   (South Korea)

Author keywords

Expression level; Genetic polymorphism; Interindividual variations; Organic anion transporter (OAT); SLC22A6; SLC22A7

Indexed keywords

ANION; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 2;

AMINO ACID SUBSTITUTION; ANION TRANSPORT; ARTICLE; CONTROLLED STUDY; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; KOREA; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; WESTERN BLOTTING;

BASE SEQUENCE; BLOTTING, WESTERN; DNA PRIMERS; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; LIVER; ORGANIC ANION TRANSPORT PROTEIN 1; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; POLYMORPHISM, SINGLE NUCLEOTIDE; REPUBLIC OF KOREA;

AVENA;

EID: 70449535432     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.10.015     Document Type: Article

References (37)

1. Eraly S.A., Monte J.C., and Nigam S.K. Novel slc22 transporter homologs in fly, worm, and human clarify the phylogeny of organic anion and cation transporters. Physiol Genomics 18 (2004) 12-24
2. Sekine T., Cha S.H., and Endou H. The multispecific organic anion transporter (OAT) family. Pflugers Arch 440 (2000) 337-350
3. Kerb R. Implications of genetic polymorphisms in drug transporters for pharmacotherapy. Cancer Lett 234 (2006) 4-33
4. Meier Y., Pauli-Magnus C., Zanger U.M., et al. Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver. Hepatology 44 (2006) 62-74
5. Evans W.E., and Relling M.V. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286 (1999) 487-491
6. Weinshilboum R. Inheritance and drug response. N Engl J Med 348 (2003) 529-537
7. Leabman M.K., and Giacomini K.M. Estimating the contribution of genes and environment to variation in renal drug clearance. Pharmacogenetics 13 (2003) 581-584
8. Yin O.Q., Tomlinson B., and Chow M.S. Variability in renal clearance of substrates for renal transporters in chinese subjects. J Clin Pharmacol 46 (2006) 157-163
9. Sakata T., Anzai N., Shin H.J., et al. Novel single nucleotide polymorphisms of organic cation transporter 1 (SLC22A1) affecting transport functions. Biochem Biophys Res Commun 313 (2004) 789-793
10. Kerb R., Brinkmann U., Chatskaia N., et al. Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences. Pharmacogenetics 12 (2002) 591-595
11. Shu Y., Leabman M.K., Feng B., et al. Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1. Proc Natl Acad Sci U S A 100 (2003) 5902-5907
12. Kang H.J., Song I.S., Shin H.J., et al. Identification and functional characterization of genetic variants of human organic cation transporters in a korean population. Drug Metab Dispos 35 (2007) 667-675
13. Shu Y., Brown C., Castro R.A., et al. Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics. Clin Pharmacol Ther 83 (2008) 273-280
14. Shu Y., Sheardown S.A., Brown C., et al. Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J Clin Invest 117 (2007) 1422-1431
15. Song I.S., Shin H.J., Shim E.J., et al. Genetic variants of the organic cation transporter 2 influence the disposition of metformin. Clin Pharmacol Ther 84 (2008) 559-562
16. Song I.S., Shin H.J., and Shin J.G. Genetic variants of organic cation transporter 2 (OCT2) significantly reduce metformin uptake in oocytes. Xenobiotica 38 (2008) 1252-1262
17. You G. Structure, function, and regulation of renal organic anion transporters. Med Res Rev 22 (2002) 602-616
18. Burckhardt B.C., and Burckhardt G. Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol 146 (2003) 95-158
19. Sekine T., Miyazaki H., and Endou H. Molecular physiology of renal organic anion transporters. Am J Physiol Renal Physiol 290 (2006) F251-F261
20. Fujita T., Brown C., Carlson E.J., et al. Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1). Pharmacogenet Genomics 15 (2005) 201-209
21. Bleasby K., Hall L.A., Perry J.L., Mohrenweiser H.W., and Pritchard J.B. Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6). J Pharmacol Exp Ther 314 (2005) 923-931
22. Nies A.T., Koepsell H., Winter S., et al. Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver. Hepatology (2009)
23. Gabriel S.B., Schaffner S.F., Nguyen H., et al. The structure of haplotype blocks in the human genome. Science 296 (2002) 2225-2229
24. Enomoto A., Takeda M., Shimoda M., et al. Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. J Pharmacol Exp Ther 301 (2002) 797-802
25. Xu G., Bhatnagar V., Wen G., Hamilton B.A., Eraly S.A., and Nigam S.K. Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)]. Kidney Int 68 (2005) 1491-1499
26. Iida A., Saito S., Sekine A., et al. Catalog of 258 single-nucleotide polymorphisms (SNPs) in genes encoding three organic anion transporters, three organic anion-transporting polypeptides, and three NADH:ubiquinone oxidoreductase flavoproteins. J Hum Genet 46 (2001) 668-683
27. Vormfelde S.V., Schirmer M., Hagos Y., et al. Torsemide renal clearance and genetic variation in luminal and basolateral organic anion transporters. Br J Clin Pharmacol 62 (2006) 323-335
28. Shitara Y., and Sugiyama Y. Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions. Pharmacol Ther 112 (2006) 71-105
29. Kameyama Y., Yamashita K., Kobayashi K., Hosokawa M., and Chiba K. Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells. Pharmacogenet Genomics 15 (2005) 513-522
30. Tachibana-Iimori R., Tabara Y., Kusuhara H., et al. Effect of genetic polymorphism of OATP-C (SLCO1B1) on lipid-lowering response to HMG-CoA reductase inhibitors. Drug Metab Pharmacokinet 19 (2004) 375-380
31. Morimoto K., Oishi T., Ueda S., Ueda M., Hosokawa M., and Chiba K. A novel variant allele of OATP-C (SLCO1B1) found in a Japanese patient with pravastatin-induced myopathy. Drug Metab Pharmacokinet 19 (2004) 453-455
32. Link E., Parish S., Armitage J., et al. SLCO1B1 variants and statin-induced myopathy - a genomewide study. N Engl J Med 359 (2008) 789-799
33. Igel M., Arnold K.A., Niemi M., et al. Impact of the SLCO1B1 polymorphism on the pharmacokinetics and lipid-lowering efficacy of multiple-dose pravastatin. Clin Pharmacol Ther 79 (2006) 419-426
34. Hedman M., Antikainen M., Holmberg C., et al. Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes. Br J Clin Pharmacol 61 (2006) 706-715
35. Zhang W., Chen B.L., Ozdemir V., et al. SLCO1B1 521T→C functional genetic polymorphism and lipid-lowering efficacy of multiple-dose pravastatin in Chinese coronary heart disease patients. Br J Clin Pharmacol 64 (2007) 346-352
36. Niemi M., Schaeffeler E., Lang T., et al. High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1). Pharmacogenetics 14 (2004) 429-440
37. Niemi M., Backman J.T., Kajosaari L.I., et al. Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics. Clin Pharmacol Ther 77 (2005) 468-478